Effie Apostolou - Jane Coffin Childs Memorial Fund.
The Laboratory of Konrad Hochedlinger, PhD at Massachusetts General Hospital is particularly interested in the biology of embryonic stem.
Konrad Hochedlinger, PhD Hochedlinger Laboratory Natalie Bourdon, BA Bruno Di Stefano, PhD Yvonne Hernandez Konrad Hochedlinger, PhD Michael Hoetker, MD Aaron Huebner, PhD Christopher Li, BA Nikolaos Tsopoulidis, PhD Masaki Yagi, PhD The Hochedlinger lab is studying the mechanisms underlying cell fate transitions by using transcription-factor.
Konrad Hochedlinger, PhD, receives the ISSCR Outstanding Young Investigator Award July 10, 2009 HSCI Principal Faculty member Konrad Hochedlinger, PhD, received the ISSCR Outstanding Young Investigator Award at the ISSCR 7th Annual Meeting in Barcelona.
After completing her MSc, Marti joined Konrad Hochedlinger’s lab in Boston, MA, to do her PhD research that she hopes to soon finalize. Currently, she is completing her medical degree at the Erasmus MC.
About Konrad Hochedlinger, PhD Konrad Hochedlinger, PhD, is a Professor of Genetics at Harvard Medical School and a member of the Department of Molecular Biology, the Center for Regenerative Medicine and the Cancer Center at the Massachusetts General Hospital.
I was born at Naoussa, a small town in northern Greece. I studied biology at Aristotle University of Thessaloniki and pursued my PhD on molecular biology at the medical school of the National University in Athens. While working at Dr. Dimitris Thanos lab for my PhD thesis — “In vivo study of the dynamics of transcriptional complexes.
For my MS thesis work, I joined the laboratory of Konrad Hochedlinger at Massachusetts General Hospital to study the role of epigenetic modulators, both proteins and long non-coding (lnc)RNAs, in transcription factor-mediated reprogramming to pluripotency.
Dissertation Advisor: Dr. Konrad Hochedlinger Author: Ryan Michael Walsh Loss of the histone demethylase Phf8 is compatible with development but confers resilience to anxiety and depression Abstract Phf8 is a histone demethylase associated with human developmental disorders and cancer. Early studies of Phf8 in humans indicated that inactivating.
Konrad Hochedlinger, PhD, and colleagues’ paper in Nature showing that an important cluster of genes is inactivated in induced pluripotent stem cells (iPSCs) that do not have the full development potential of embryonic stem cells.
Konrad Hochedlinger is an Assistant Professor of Medicine at Harvard Medical School, a Principal Faculty at the Harvard Stem Cell Institute and an Investigator at the Cancer Center and Center for Regenerative Medicine at the Massachusetts General Hospital. He received his B.Sc. in biology and his Ph.D. in genetics from the University of Vienna. From 1998-1999, he worked with Erwin Wagner at.
Konrad Hochedlinger is Faculty Member at Harvard Stem Cell Institute. View Konrad Hochedlinger’s professional profile on Relationship Science, the database of decision makers.
Amy Wagers, PhD, Konrad Hochedlinger, PhD, Kevin Eggan, PhD, and Bradley Bernstein, MD, PhD were winners of the Howard Hughes Medical Institute Early Career Science Competition.To read more, see page one. Doug Melton, PhD, was selected as one of TIME magazine’s 100 most influential people for 2009. This is the second time he has.
Konrad Hochedlinger: ISSCR Outstanding Young Investigator for 2009 The inaugural ISSCR Outstanding Young Investigator Award was awarded to Konrad Hochedlinger in recognition of exceptional achievements in the early part of his independent stem cell research career. The International Society for Stem Cell Research (ISSCR) has.
